Scarica l'app Stockscreener
0.3987
2.80%
-0.0115
Pre-mercato:
.39
-0.0087
-2.18%
Precedente Chiudi:
$0.4102
Aprire:
$0.4102
Volume 24 ore:
228.66K
Relative Volume:
0.40
Capitalizzazione di mercato:
$24.08M
Reddito:
$2.29M
Utile/perdita netta:
$-18.63M
Rapporto P/E:
-0.7096
EPS:
-0.5619
Flusso di cassa netto:
$-19.32M
1 W Prestazione:
-5.30%
1M Prestazione:
-23.84%
6M Prestazione:
-34.50%
1 anno Prestazione:
-67.85%
Intervallo 1D:
$0.3877
$0.4199
Intervallo di 1 settimana:
$0.3877
$0.4498
Portata 52W:
$0.3067
$1.29
Femasys Inc Stock (FEMY) Company Profile
Nome
Femasys Inc
Settore
Industria
Telefono
770-500-3910
Indirizzo
3950 JOHNS CREEK COURT, SUWANEE
Compare FEMY vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.3987 | 25.18M | 2.29M | -18.63M | -19.32M | -0.5619 |
ISRG
Intuitive Surgical Inc
|
478.82 | 160.28B | 10.58B | 2.99B | 2.49B | 8.2405 |
BDX
Becton Dickinson Co
|
154.85 | 44.57B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
46.23 | 38.56B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
75.86 | 37.93B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
219.51 | 32.23B | 5.40B | 1.49B | 1.78B | 10.12 |
Femasys Inc Stock (FEMY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-20 | Iniziato | Laidlaw | Buy |
Femasys Inc Borsa (FEMY) Ultime notizie
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026 - The Manila Times
Femasys aims to bring first-line fertility treatment into OB/GYN offices - Stock Titan
Femasys (FEMY) Stock Jumps on Deal (+0.71%) 2026-04-18Community Watchlist - UBND thành phố Hải Phòng
Femasys partners with AMI Technologies for Israel market entry By Investing.com - Investing.com India
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio - Sahm
Femasys (FEMY) Forms Partnership with AMI Technologies to Expand Fertility Portfolio - GuruFocus
Femasys partners with AMI Technologies for Israel market entry - Investing.com
Femasys Enters into A Strategic Partnership with Ami Technologies - marketscreener.com
Weekly Trades: Is Femasys Inc stock undervalued right now2026 Review & AI Enhanced Execution Alerts - baoquankhu1.vn
Is Femasys (FEMY) Stock Breaking Out | Price at $0.40, Up 0.76%Expert Stock Picks - Cổng thông tin điện tử tỉnh Lào Cai
Femasys (FEMY) Falls 27% as Firm to Raise $8-Million from Share Sale - MSN
Market Rankings: Can Femasys Inc sustain its profitabilityBond Market & Fast Moving Stock Trade Plans - baoquankhu1.vn
What is market pressure on Femasys (FEMY) Stock | Price at $0.39, Down 1.32%Community Chart Signals - Xã Thanh Hà
Femasys (NASDAQ: FEMY) targets reverse split and dilutive note, warrant share issuances - Stock Titan
Can Femasys Inc grow without external funding2026 Closing Moves & Advanced Technical Signal Analysis - baoquankhu1.vn
Is Femasys (FEMY) Stock Good for Portfolio | Price at $0.43, Down 2.16%Open Stock Picks - Xã Vĩnh Công
Femasys appoints John Canning as COO - MSN
Femasys Inc reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets
Lake Street Maintains Femasys(FEMY.US) With Buy Rating, Maintains Target Price $1.5 - Moomoo
Femasys names John Canning as chief operating officer By Investing.com - Investing.com South Africa
FEMY SEC FilingsFEMASYS INC 10-K, 10-Q, 8-K Forms - Stock Titan
FEMASYS (FEMY) COO awarded 150,000 stock options at $0.38 exercise price - Stock Titan
Femasys (FEMY) COO John Canning discloses ownership of 30,000 shares - Stock Titan
Femasys Names John Canning as New Chief Operating Officer - TipRanks
Femasys Inc. Appoints John Canning as Chief Operating Officer, Effective March 30, 2026 - marketscreener.com
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth - bitget.com
Femasys names John Canning as chief operating officer - Investing.com
Femasys names John Canning as Chief Operating Officer - TradingView
Veteran MedTech leader John Canning joins Femasys (NASDAQ: FEMY) as COO - Stock Titan
Femasys earnings beat by $0.12, revenue fell short of estimates - ca.investing.com
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update - National Today
Femasys 2025 10-K: Revenue $2.29M, Net loss per share $(0.47) - TradingView — Track All Markets
Femasys (NASDAQ: FEMY) advances FemBloc and FemaSeed women’s health platform - Stock Titan
Femasys Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Femasys 2025 sales jump on FemBloc demand - TradingView — Track All Markets
Femasys (NASDAQ: FEMY) details 2025 results and FemBloc FINALE trial - Stock Titan
Femasys Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Femasys Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
FEMY Should I Buy - Intellectia AI
Femasys (FEMY) price target decreased by 17.74% to 4.34 - MSN
Femasys (FEMY) CFO receives 34,122 Series D-1 warrants at $0.58 - Stock Titan
Femasys (NASDAQ: FEMY) director awarded 34,122 Series D-1 warrants - Stock Titan
Board seeks reverse split, Nasdaq‑rule approval for issuances (FEMY) - Stock Titan
Femasys (NASDAQ: FEMY) director discloses notes, warrants and share stake - Stock Titan
Femasys Inc. Enters Omnibus Amendment and Issues Series D-1 Warrants – SEC 8-K Filing March 2026 - Minichart
Femasys amends warrants and notes, appoints new director to board By Investing.com - Investing.com India
Femasys amends warrants and notes, appoints new director to board - Investing.com
Femasys (NASDAQ: FEMY) director receives stock options for 35,200 shares - Stock Titan
Femasys Amends Financing Terms and Issues New Warrants - TipRanks
Femasys enters omnibus amendment and consent agreement on March 19, 2026SEC filing - MarketScreener
Femasys Enters Omnibus Amendment And Consent Agreement On March 19, 2026SEC Filing - TradingView
Femasys Inc Azioni (FEMY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.55%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):